eBioscience Fixation/Permeabilization Concentrate and 5 more items

Life Technologies Corporation was awarded a contract by the University of Virginia on July 3, 2026, with a cumulative value of $2,178.38. The contract is designated as A207_PO-0453818 and is located in Virginia. The award encompasses the procurement of specialized life sciences research reagents and materials, all of which are to be delivered to Nicholas Maximilian Hagspiel at the University of Virginia.

The contract includes six line items consisting of flow cytometry and immunology research products manufactured by eBioscience, a Life Technologies subsidiary. These items include fixation and permeabilization concentrates ($142.56), polyclonal antibodies targeting ZO-1 and REG3G proteins ($433.50 and $390.00, respectively), compensation beads for flow cytometry ($408.32), and monoclonal antibodies targeting IL-22 and ROR gamma (t) proteins conjugated with fluorescent labels ($384.00 and $420.00, respectively). The reagents appear to support immunological research applications, likely involving flow cytometric analysis and antibody-based detection methodologies.